Neptune Technologies & Bioresources Inc Revenue 2009-2019 | NEPT

Neptune Technologies & Bioresources Inc revenue from 2009 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Neptune Technologies & Bioresources Inc Annual Revenue
(Millions of US $)
2019 $19
2018 $22
2016 $17
2015 $17
2015 $0
2014 $19
2014 $0
2013 $26
2013 $0
2012 $19
2012 $0
2011 $16
2011 $0
2010 $11
2010 $0
2009 $8
2009 $0
Neptune Technologies & Bioresources Inc Quarterly Revenue
(Millions of US $)
Q4 2019 $4
Q3 2018 $5
Q2 2018 $5
Q1 2018 $4
Q3 2016 $9
Q2 2016 $9
Q1 2016 $9
Q4 2016 $9
Q4 2016 $0
Q3 2015 $4
Q2 2015 $3
Q1 2015 $2
Q4 2015 $3
Q3 2014 $4
Q2 2014 $2
Q1 2014 $3
Q4 2014 $3
Q3 2013 $4
Q2 2013 $5
Q1 2013 $6
Q4 2013 $4
Q4 2013 $0
Q3 2012 $7
Q2 2012 $8
Q1 2012 $6
Q4 2012 $5
Q3 2011 $5
Q2 2011 $4
Q1 2011 $4
Q4 2011 $4
Q3 2010 $4
Q2 2010 $4
Q1 2010 $4
Q4 2010 $5
Q3 2009 $4
Q2 2009 $1
Q1 2009 $3
Q4 2009 $4
Q3 2008 $2
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.348B $0.018B
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.051B 28.16
Medtronic (MDT) Ireland $130.762B 18.68
Stryker (SYK) United States $72.931B 26.03
Boston Scientific (BSX) United States $56.210B 26.95
Baxter (BAX) United States $39.757B 25.06
Zimmer Biomet Holdings (ZBH) United States $24.054B 15.45
Smith & Nephew SNATS (SNN) United Kingdom $18.710B 0.00
ResMed (RMD) United States $16.933B 32.35
Canopy Growth (CGC) Canada $14.186B 0.00
Bio-Rad Laboratories (BIO) United States $8.893B 47.15
Aurora Cannabis (ACB) Canada $7.667B 75.60
Hill-Rom Holdings (HRC) United States $6.972B 21.14
Insulet (PODD) United States $6.868B 500.39
Perrigo (PRGO) Ireland $5.872B 9.93
Haemonetics (HAE) United States $5.747B 46.91
GW Pharmaceuticals (GWPH) United Kingdom $5.154B 0.00
ICU Medical (ICUI) United States $4.983B 29.73
Hutchison China MediTech (HCM) China $3.506B 0.00
Neogen (NEOG) United States $3.232B 52.55
NuVasive (NUVA) United States $3.005B 24.54
Agios Pharmaceuticals (AGIO) United States $2.821B 0.00
National Vision Holdings (EYE) United States $2.350B 50.07
Quidel (QDEL) United States $2.233B 23.18
Aphria (APHA) $1.702B 0.00
Cardiovascular Systems (CSII) United States $1.388B 797.00
Phibro Animal Health (PAHC) United States $1.174B 17.58
AtriCure (ATRC) United States $1.144B 0.00
VAREX IMAGING (VREX) United States $1.089B 23.12
Lantheus Holdings (LNTH) United States $1.027B 27.27
OrganiGram Holdings (OGI) Canada $0.969B 0.00
NanoString Technologies (NSTG) United States $0.909B 0.00
PetIQ (PETQ) United States $0.837B 20.34
Quanterix (QTRX) United States $0.834B 0.00
Omeros (OMER) United States $0.795B 0.00
MacroGenics (MGNX) United States $0.743B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.724B 20.31
TG Therapeutics (TGTX) United States $0.639B 0.00
Cerus (CERS) United States $0.629B 0.00
Surmodics (SRDX) United States $0.558B 81.06
OraSure Technologies (OSUR) United States $0.530B 24.40
LeMaitre Vascular (LMAT) United States $0.513B 24.82
Meridian Bioscience (VIVO) United States $0.497B 15.18
Evolus (EOLS) United States $0.377B 0.00
Vapotherm (VAPO) United States $0.339B 0.00
BioLife Solutions (BLFS) United States $0.333B 104.06
Utah Medical Products (UTMD) United States $0.300B 20.78
Zynex (ZYXI) United States $0.282B 29.17
Rockwell Medical (RMTI) United States $0.241B 0.00
Bovie Medical (APYX) United States $0.213B 0.00
Cytosorbents (CTSO) United States $0.195B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Owens & Minor (OMI) United States $0.177B 3.75
Fonar (FONR) United States $0.135B 7.09
Female Health (VERU) United States $0.127B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
BRAINSWAY LTD (BWAY) Israel $0.094B 0.00
Surface Oncology (SURF) United States $0.092B 0.00
United-Guardian (UG) United States $0.087B 19.15
Neurotrope (NTRP) United States $0.080B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Trinity Biotech (TRIB) Ireland $0.044B 15.21
GUARDION HEALTH (GHSI) United States $0.036B 0.00
Senestech (SNES) United States $0.034B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.026B 0.00
Insys Therapeutics (INSY) United States $0.025B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.016B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.82